Cheryl Hirsch-Ginsberg, M.D.
Department of Laboratory Medicine, Division of Pathology-Lab Medicine Div
Present Title & Affiliation
Primary Appointment
Professor, Department of Laboratory Medicine, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 1981 | University of Louisville School of Medicine, Louisville, KY, USA, MD, Medicine |
| 1977 | Washington University, St. Louis, MO, USA, BA, Biology |
Postgraduate Training
| 1985-1987 | Fellow, Hematopathology Training Program, The University of Texas MD Anderson Cancer Center, Houston, TX |
| 1981-1985 | Resident, Michael Reese Hospital and Medical Center, Chicago, IL |
Board Certifications
| 1988 | American Board of Pathology, Hematology |
| 1985 | American Board of Pathology, Anatomic and Clinical |
| 1982 | National Boards of Medical Examiners |
Experience & Service
Administrative Appointments/Responsibilities
Deputy Department Chair, Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - Present
Institutional Committee Activities
member, Data Governance Council, 2016 - Present
member, Critical Results Notification Working Group, 2016 - 2016
member, EHR Faculty committee, 2014 - Present
member representing Pathology and Laboratory medicine, ICT committee for Epic Implementation, 2014 - Present
member representing Pathology and laboratory medicine, ICDT-10 amabassadors, 2013 - Present
member, Executive council of PRS, 2010 - 2013
Member, Diversity Council, (Faculty Senate Representative), 2005 - 2012
Alternate member, Credentials Committee of the Medical staff, 2002 - Present
Selected Publications
Peer-Reviewed Articles
- Strati P, Bose P, Lyle L, Gaw K, Zhou L, Pierce SA, Huynh-Lu J, Hirsch-Ginsberg CF, Bueso-Mendoza DE, Bueso-Ramos CE, Verstovsek S. Novel hematological parameters for the evaluation of patients with myeloproliferative neoplasms: the immature platelet and reticulocyte fractions. Ann Hematol 96(5):733-738, 2017. e-Pub 2017. PMID: 28247057.
- Reitzel RA, Rosenblatt J, Hirsh-Ginsberg C, Murray K, Chaftari AM, Hachem R, Raad I. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections. Antimicrob Agents Chemother 60(9):5175-81, 2016. e-Pub 2016. PMID: 27297475.
- Mallampati S, Leng X, Ma H, Zeng J, Li J, Wang H, Lin K, Lu Y, Yang Y, Sun B, Gong Y, Lee JS, Konopleva M, Andreeff M, Arlinghaus RB, Cai Z, Fang B, Shen H, Han X, Hirsch-Ginsberg CF, Gao X, Paranjape AN, Mani SA, Clise-Dwyer K, Sun X. Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia. Blood 125(19):2968-73, 2015. e-Pub 2015. PMID: 25712988.
- Shah DR, Daver N, Borthakur G, Hirsch-Ginsberg C, Oo TH. Pernicious Anemia With Spuriously Normal Vitamin B12 Level Might Be Misdiagnosed As Myelodysplastic Syndrome. Clin Lymphoma Myeloma Leuk 14(4):e141-3, 2014. e-Pub 2014. PMID: 24630920.
Patient Reviews
CV information above last modified June 20, 2023